Cargando…
Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
Cancer cell metabolism is required to support the biosynthetic demands of cell growth and cell division, and to maintain reduction oxidaton (redox) homeostasis. This study was designed to test the effects of glucose and glutamine on ovarian cancer cell growth and explore the inter-relationship betwe...
Autores principales: | Sun, Li, Yin, Yajie, Clark, Leslie H., Sun, Wenchuan, Sullivan, Stephanie A., Tran, Arthur-Quan, Han, Jianjun, Zhang, Lu, Guo, Hui, Madugu, Esther, Pan, Tommy, Jackson, Amanda L., Kilgore, Joshua, Jones, Hannah M., Gilliam, Timothy P., Zhou, Chunxiao, Bae-Jump, Victoria L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609942/ https://www.ncbi.nlm.nih.gov/pubmed/28969010 http://dx.doi.org/10.18632/oncotarget.18854 |
Ejemplares similares
-
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer
por: Jackson, Amanda L., et al.
Publicado: (2017) -
SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian Cancer
por: Tran, Arthur-Quan, et al.
Publicado: (2021) -
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
por: Ahmed, Shanzay, et al.
Publicado: (2023) -
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
por: Xu, Guangxu, et al.
Publicado: (2021) -
NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo
por: Zhang, Lu, et al.
Publicado: (2016)